AquaMed Technologies Inc., HepaLife Technologies deal

HepaLife completed its previously announced acquisition of drug delivery company AquaMed in a stock deal.

Read the full 153 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE